1. Off‐label use of tacrolimus in children with glomerular disease: Effectiveness, safety and pharmacokinetics
   Guo‐Xiang Hao et al, 2020, British Journal of Clinical Pharmacology CrossRef
2. Understanding the podocyte immune responses in proteinuric kidney diseases: from pathogenesis to therapy
   Hong Jiang et al, 2024, Frontiers in Immunology CrossRef
3. Inhibiting the urokinase‐type plasminogen activator receptor system recovers STZ‐induced diabetic nephropathy
   Massimo Dal Monte et al, 2019, Journal of Cellular and Molecular Medicine CrossRef
4. NETosis: an emerging therapeutic target in renal diseases
   Márk Juha et al, 2023, Frontiers in Immunology CrossRef
5. Tacrolimus ameliorates tubulointerstitial inflammation in diabetic nephropathy via inhibiting the NFATc1/TRPC6 pathway
   Shumin Zhang et al, 2020, Journal of Cellular and Molecular Medicine CrossRef
6. Tacrolimus Protects Podocytes from Apoptosis via Downregulation of TRPC6 in Diabetic Nephropathy
   Ruixia Ma et al, 2021, Journal of Diabetes Research CrossRef
7. Herba Artemisiae Capillaris Extract Prevents the Development of Streptozotocin-Induced Diabetic Nephropathy of Rat
   Jianan Geng et al, 2018, Evidence-Based Complementary and Alternative Medicine CrossRef
8. Renoprotective effects of Gushen Jiedu capsule on diabetic nephropathy in rats
   Lei Zhang et al, 2020, Scientific Reports CrossRef